A urologist’s contemporary guide to penile cancer

References

• Hakenberg OW, Comperat E, Minhas S, Necchi A, Protzel C, Watkin N. EAU guidelines on penile cancer. Eur Assoc Urology 2014. Available from http://www.uroweb.org. [Last accessed 14 May 2015].
   Google Scholar
• Matin SF, Cormier JN, Ward JF, Pisters LL, Wood CG, Dinney CP, et al. Phase 1 prospective evaluation of the oncological adequacy of robotic assisted video-endoscopic inguinal lymphadenectomy in patients with penile carcinoma. BJU Int 2013;111:1068–74.
   PubMed Web of Science ®Google Scholar
• Zargar-Shoshtari K, Sharma P, Djajadiningrat R, Catanzaro M, Ye DW, Zhu Y, et al. Extent of pelvic lymph node dissection in penile cancer may impact survival. World J Urol 2015. [Epub ahead of print].
   Google Scholar
• Barnholtz-Sloan JS, Maldonado JL, Pow-sang J, Giuliano AR. Incidence trends in primary malignant penile cancer. Urol Oncol 2007;25:361–7.
   PubMed Web of Science ®Google Scholar
• Arya M, Li R, Pegler K, Sangar V, Kelly JD, Minhas S, et al. Long-term trends in incidence, survival and mortality of primary penile cancer in England. Cancer Causes Control 2013;24:2169–76.
   PubMed Web of Science ®Google Scholar
• Kirrander P, Sherif A, Friedrich B, Lambe M, Håkansson U. Steering Committee of the Swedish National Penile Cancer Register. The Swedish National Penile Cancer Register: incidence, tumour characteristics, management and survival. BJU Int 2014. [Epub ahead of print].
   PubMedGoogle Scholar
• Frisch M, Van Howe RS. Is the trend in primary penile cancer in England real? Cancer Causes Control 2014;25:405–6.
   PubMed Web of Science ®Google Scholar
• Frisch M, Ulff-Moller CJ, Simonsen J. Questionable evidence of increasing incidence of invasive penile cancer in Denmark. Cancer Causes Control 2012;23:659–60; author reply 661–2.
   PubMed Web of Science ®Google Scholar
• Goodman MT, Hernandez BY, Shvetsov YB. Demographic and pathologic differences in the incidence of invasive penile cancer in the United States, 1995–2003. Cancer Epidemiol Biomarkers Prev 2007;16:1833–9.
   PubMed Web of Science ®Google Scholar
• Graafland NM, Verhoeven RH, Coebergh JW, Horenblas S. Incidence trends and survival of penile squamous cell carcinoma in the Netherlands. Int J Cancer 2011;128:426–32.
   PubMed Web of Science ®Google Scholar
• Ulff-Møller CJ, Simonsen J, Frisch M. Marriage, cohabitation and incidence trends of invasive penile squamous cell carcinoma in Denmark 1978–2010. Int J Cancer 2013;133:1173–9.
   PubMed Web of Science ®Google Scholar
• Baldur-Felskov B, Hannibal CG, Munk C, Kjaer SK. Increased incidence of penile cancer and high-grade penile intraepithelial neoplasia in Denmark 1978–2008: a nationwide population-based study. Cancer Causes Control 2012;23:273–80.
   PubMed Web of Science ®Google Scholar
• Winter A, Vohmann C, Wawroschek F, Kieschke J. Increase in uro-oncological health care needs due to demographic change: extrapolation of cancer incidence numbers through 2030 as a basis for directed regional planning. Urologe A 2014. [Epub ahead of print].
   PubMedGoogle Scholar
• Madsen BS, van den Brule AJ, Jensen HL, Wohlfahrt J, Frisch M. Risk factors for squamous cell carcinoma of the penis – population-based case–control study in Denmark. Cancer Epidemiol Biomarkers Prev 2008;17:2683–91.
   PubMed Web of Science ®Google Scholar
• Chalya PL, Rambau PF, Masalu N, Simbila S. Ten-year surgical experiences with penile cancer at a tertiary care hospital in northwestern Tanzania: a retrospective study of 236 patients. World J Surg Oncol 2015;13:71.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893–917.
   PubMed Web of Science ®Google Scholar
• Frisch M, Friis S, Kjaer SK, Melbye M. Falling incidence of penis cancer in an uncircumcised population (Denmark 1943–90). BMJ 1995;311:1471.
   PubMed Web of Science ®Google Scholar
• Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, et al. Global burden of human papillomavirus and related diseases. Vaccine 2012;30:F12–23.
   PubMed Web of Science ®Google Scholar
• Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA, et al. Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int J Cancer 2005;116:606–16.
   PubMed Web of Science ®Google Scholar
• Bleich AR. Prophylaxis of penile carcinoma. JAMA 1950;143:1054–7.
   PubMed Web of Science ®Google Scholar
• Bleeker MC, Heideman DA, Snijders PJ, Horenblas S, Dillner J, Meijer CJ. Penile cancer: epidemiology, pathogenesis and prevention. World J Urol 2009;27:141–50.
   PubMed Web of Science ®Google Scholar
• Hellberg D, Valentin J, Eklund T, Nilsson S. Penile cancer: is there an epidemiological role for smoking and sexual behaviour? BMJ (Clin Res Ed) 1987;295:1306–8.
   PubMed Web of Science ®Google Scholar
• Jakobsen JK, Krarup KP, Sommer P, Nerstrom H, Bakholdt V, Sørensen JA, et al. Pre-treatment diagnostic characteristics of 321 penile cancer patients – a national retrospective study from Denmark. The Annual Meeting of the Danish Pathology Society, 13–15 March 2014, Herlev, Denmark. Acta Pathologica Microbiol Immunol Scand 2014;122.
   Google Scholar
• Nielson CM, Schiaffino MK, Dunne EF, Salemi JL, Giuliano AR. Associations between male anogenital human papillomavirus infection and circumcision by anatomic site sampled and lifetime number of female sex partners. J Infect Dis 2009;199:7–13.
   PubMed Web of Science ®Google Scholar
• Castellsague X, Bosch FX, Munoz N, Meijer CJ, Shah KV, de Sanjose S, et al. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med 2002;346:1105–12.
   PubMed Web of Science ®Google Scholar
• Albero G, Castellsague X, Lin HY, Fulp W, Villa LL, Lazcano-Ponce E, et al. Male circumcision and the incidence and clearance of genital human papillomavirus (HPV) infection in men: the HPV Infection in Men (HIM) cohort study. BMC Infect Dis 2014;14:75.
   PubMed Web of Science ®Google Scholar
• Backes DM, Kurman RJ, Pimenta JM, Smith JS. Systematic review of human papillomavirus prevalence in invasive penile cancer. Cancer Causes Control 2009;20:449–57.
   PubMed Web of Science ®Google Scholar
• Flaherty A, Kim T, Giuliano A, Magliocco A, Hakky TS, Pagliaro LC, et al. Implications for human papillomavirus in penile cancer. Urol Oncol 2014;32:53.e1–8.
   PubMed Web of Science ®Google Scholar
• Blomberg M, Friis S, Munk C, Bautz A, Kjaer SK. Genital warts and risk of cancer: a Danish study of nearly 50 000 patients with genital warts. J Infect Dis 2012;205:1544–53.
   PubMed Web of Science ®Google Scholar
• Tsen HF, Morgenstern H, Mack T, Peters RK. Risk factors for penile cancer: results of a population-based case–control study in Los Angeles County (United States). Cancer Causes Control 2001;12:267–77.
   PubMed Web of Science ®Google Scholar
• Engels EA, Biggar RJ, Hall HI, Cross H, Crutchfield A, Finch JL, et al. Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer 2008;123:187–94.
   PubMed Web of Science ®Google Scholar
• Mentrikoski MJ, Stelow EB, Culp S, Frierson HFJr, Cathro HP. Histologic and immunohistochemical assessment of penile carcinomas in a North American population. Am J Surg Pathol 2014;38:1340–8.
   PubMed Web of Science ®Google Scholar
• Paolino G, Panetta C, Cota C, Muscardin L, Donati P, Di Carlo A. Lichen sclerosus and the risk of malignant progression: a case series of 159 patients. G Ital Dermatol Venereol 2013;148:673–8.
   PubMed Web of Science ®Google Scholar
• Adamou A, Baselga J, Geissler J, Guido G. The Burden and the Challenges of Rare Cancers. 2011. Available from: http://www.rarecancerseurope.org/About-Rare-Cancers/The-Burden-and-the-Challenges-of-Rare-Cancers?hit=ehp. [Last accessed 14 May 2015].
   Google Scholar
• Jakobsen JK, Krarup KP, Kirrander P, Hakansson U, Kaipia A, Perttila I, et al. Penile cancer in Scandinavia: current practice and future perspectives. Scand J Urol 2014;1–3. [Epub ahead of print].
   PubMedGoogle Scholar
• Wolbarst AL. Is circumcision a prophylactic against penis cancer? Cancer 1926;3:301–9.
   Google Scholar
• Frisch M, Aigrain Y, Barauskas V, Bjarnason R, Boddy SA, Czauderna P, et al. Cultural bias in the AAP’s 2012 Technical Report and Policy Statement on male circumcision. Pediatrics 2013;131:796–800.
   PubMed Web of Science ®Google Scholar
• Wamai RG, Morris BJ, Bailey RC, Klausner JD, Boedicker MN. Male circumcision for protection against HIV infection in sub-Saharan Africa: the evidence in favour justifies the implementation now in progress. Glob Public Health 2015;10:639–66.
   PubMed Web of Science ®Google Scholar
• Giuliano AR, Palefsky JM, Goldstone S, Moreira EDJr, Penny ME, Aranda C, et al. Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. N Engl J Med 2011;364:401–11.
   PubMed Web of Science ®Google Scholar
• Bonanni P, Bechini A, Donato R, Capei R, Sacco C, Levi M, et al. Human papilloma virus vaccination: impact and recommendations across the world. Ther Adv Vaccines 2015;3:3–12.
   Google Scholar
• Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, et al. Comprehensive control of human papillomavirus infections and related diseases. Vaccine 2013;31:G1–31.
   Google Scholar
• Skeppner E, Andersson SO, Johansson JE, Windahl T. Initial symptoms and delay in patients with penile carcinoma. Scand J Urol Nephrol 2012;46:319–25.
   PubMed Web of Science ®Google Scholar
• Kakies C, Lopez-Beltran A, Comperat E, Erbersdobler A, Grobholz R, Hakenberg OW, et al. Reproducibility of histopathologic tumor grading in penile cancer – results of a European project. Virchows Arch 2014;464:453–61.
   PubMed Web of Science ®Google Scholar
• Hegarty PK, Eardley I, Heidenreich A, McDougal WS, Minhas S, Spiess PE, et al. Penile cancer: organ-sparing techniques. BJU Int 2014;114:799–805.
   PubMed Web of Science ®Google Scholar
• Hakansson U, Kirrander P, Uvelius B, Baseckas G, Torbrand C. Organ-sparing reconstructive surgery in penile cancer: initial experiences at two Swedish referral centres. Scand J Urol 2015;49:149–54.
   PubMed Web of Science ®Google Scholar
• Nieweg OE, Uren RF, Thompson JF. The history of sentinel lymph node biopsy. Cancer J 2015;21:3–6.
   PubMed Web of Science ®Google Scholar
• Stuiver MM, Djajadiningrat RS, Graafland NM, Vincent AD, Lucas C, Horenblas S. Early wound complications after inguinal lymphadenectomy in penile cancer: a historical cohort study and risk-factor analysis. Eur Urol 2013;64:486–92.
   PubMed Web of Science ®Google Scholar
• Sharma P, Djajadiningrat R, Zargar-Shoshtari K, Catanzaro M, Zhu Y, Nicolai N, et al. Adjuvant chemotherapy is associated with improved overall survival in pelvic node-positive penile cancer after lymph node dissection: a multi-institutional study. Urol Oncol 2015. [Epub ahead of print].
   Google Scholar
• Protzel C, Seitz AK, Hakenberg OW, Retz M. Neoadjuvant, adjuvant and palliative chemotherapy of penile cancer. Urologe A 2013;52:1556–60; 1562–3.
   PubMedGoogle Scholar
• Leijte JA, Kirrander P, Antonini N, Windahl T, Horenblas S. Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients. Eur Urol 2008;54:161–8.
   PubMed Web of Science ®Google Scholar
• Agarwal G, Gupta S, Spiess PE. Novel targeted therapies for the treatment of penile cancer. Expert Opin Drug Discov 2014;9:959–68.
   PubMed Web of Science ®Google Scholar